• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Improving depression severity assessment--II. Content, concurrent and external validity of three observer depression scales.

作者信息

Maier W, Heuser I, Philipp M, Frommberger U, Demuth W

机构信息

Department of Psychiatry, University of Mainz, F.R.G.

出版信息

J Psychiatr Res. 1988;22(1):13-9. doi: 10.1016/0022-3956(88)90023-4.

DOI:10.1016/0022-3956(88)90023-4
PMID:3397905
Abstract

The Hamilton Depression Scale (HAMD), the Montgomery-Asberg Depression Rating Scale (MADRS) and the Bech-Rafaelsen Melancholia Scale (BRMS) were compared with respect to content, concurrent and external validity in sample of 130 patients with a major depressive episode. The three scales did equally well in concurrent and external validity. The HAMD showed some deficiencies in content validity. The consequences for depression severity assessment are discussed.

摘要

相似文献

1
Improving depression severity assessment--II. Content, concurrent and external validity of three observer depression scales.
J Psychiatr Res. 1988;22(1):13-9. doi: 10.1016/0022-3956(88)90023-4.
2
Improving depression severity assessment--I. Reliability, internal validity and sensitivity to change of three observer depression scales.
J Psychiatr Res. 1988;22(1):3-12. doi: 10.1016/0022-3956(88)90022-2.
3
[French adaptation, concurrent validation and factorial analysis of the Bech and Rafaelsen melancholia scale].[贝克与拉费尔森忧郁症量表的法语改编、同步效度验证及因子分析]
Encephale. 1988 Nov-Dec;14(6):443-8.
4
Comparative analysis of observer depression scales.
Acta Psychiatr Scand. 1985 Sep;72(3):239-45. doi: 10.1111/j.1600-0447.1985.tb02601.x.
5
[Studies of the reliability and validity of the German version of the Montgomery-Asberg Depression Rating Scale (MADRS)].
Schweiz Arch Neurol Psychiatr (1985). 1988;139(2):51-65.
6
Latencies of the P300 component of the auditory event-related potential in depression are related to the Bech-Rafaelsen Melancholia Scale but not to the Hamilton Rating Scale for Depression.抑郁症患者听觉事件相关电位P300成分的潜伏期与贝克-拉范森躁狂量表相关，但与汉密尔顿抑郁量表无关。
Acta Psychiatr Scand. 1991 Jun;83(6):438-40. doi: 10.1111/j.1600-0447.1991.tb05571.x.
7
The validity of the Hamilton and Montgomery-Asberg depression rating scales as screening and diagnostic tools for depression in Parkinson's disease.汉密尔顿抑郁量表和蒙哥马利-阿斯伯格抑郁评定量表作为帕金森病抑郁筛查及诊断工具的有效性。
Int J Geriatr Psychiatry. 2000 Jul;15(7):644-9. doi: 10.1002/1099-1166(200007)15:7<644::aid-gps167>3.0.co;2-l.
8
On the validity of the Bech-Rafaelsen Melancholia Scale (BRMS).关于贝克-拉范森躁狂量表（BRMS）的效度。
J Affect Disord. 1999 Jul;54(1-2):119-28. doi: 10.1016/s0165-0327(98)00150-5.
9
Validity of the definite and semidefinite questionnaire version of the Hamilton Depression Scale, the Hamilton Subscale and the Melancholia Scale. Part I.汉密尔顿抑郁量表、汉密尔顿亚量表和忧郁量表的明确和半明确问卷版本的有效性。第一部分。
Eur Arch Psychiatry Clin Neurosci. 2011 Feb;261(1):37-46. doi: 10.1007/s00406-010-0106-1. Epub 2010 Mar 2.
10
A study of the psychometric properties of the Beck Depression Inventory-II, the Montgomery and Åsberg Depression Rating Scale, and the Hospital Anxiety and Depression Scale in a sample from a healthy population.对来自健康人群样本的贝克抑郁量表第二版、蒙哥马利-Åsberg抑郁评定量表和医院焦虑抑郁量表的心理测量学特性的研究。
Scand J Psychol. 2014 Feb;55(1):83-9. doi: 10.1111/sjop.12090. Epub 2013 Nov 21.

引用本文的文献

1
The cerebral and cognitive changes after intermittent theta burst stimulation (iTBS) treatment for depression: study protocol for a randomized double-blind sham-controlled trial.经颅磁刺激（TMS）治疗抑郁症后脑和认知变化：一项随机双盲假刺激对照试验研究方案。
Trials. 2024 Nov 11;25(1):752. doi: 10.1186/s13063-024-08606-8.
2
Ketamine for postoperative avoidance of depressive symptoms: the K-PASS feasibility randomised trial.氯胺酮用于术后预防抑郁症状：K-PASS可行性随机试验
BJA Open. 2023 Dec 15;9:100245. doi: 10.1016/j.bjao.2023.100245. eCollection 2024 Mar.
3
Protocol for the Ketamine for Postoperative Avoidance of Depressive Symptoms (K-PASS) feasibility study: A randomized clinical trial.
术后预防抑郁症状的氯胺酮（K-PASS）可行性研究方案：一项随机临床试验。
F1000Res. 2022 May 11;11:510. doi: 10.12688/f1000research.121529.1. eCollection 2022.
4
Effects of Open-Label, Adjunctive Ganaxolone on Persistent Depression Despite Adequate Antidepressant Treatment in Postmenopausal Women: A Pilot Study.尽管抗抑郁药治疗充分，但绝经后妇女持续抑郁时加用开放式、辅助性甘羟铝的效果：一项初步研究。
J Clin Psychiatry. 2020 Jun 9;81(4):19m12887. doi: 10.4088/JCP.19m12887.
5
Predictive modeling of treatment resistant depression using data from STAR*D and an independent clinical study.使用来自 STAR*D 和一项独立临床研究的数据对治疗抵抗性抑郁症进行预测建模。
PLoS One. 2018 Jun 7;13(6):e0197268. doi: 10.1371/journal.pone.0197268. eCollection 2018.
6
Understanding the Outcomes Measures used in Huntington Disease Pharmacological Trials: A Systematic Review.了解亨廷顿病药物试验中使用的疗效指标：一项系统综述。
J Huntingtons Dis. 2014;3(3):233-52. doi: 10.3233/JHD-140115.
7
Sensitivity to changes during antidepressant treatment: a comparison of unidimensional subscales of the Inventory of Depressive Symptomatology (IDS-C) and the Hamilton Depression Rating Scale (HAMD) in patients with mild major, minor or subsyndromal depression.抗抑郁治疗期间变化的敏感性：轻度、中度或亚综合征抑郁患者的抑郁症状评定量表（IDS-C）和汉密尔顿抑郁评定量表（HAMD）的一维子量表的比较。
Eur Arch Psychiatry Clin Neurosci. 2012 Jun;262(4):291-304. doi: 10.1007/s00406-011-0263-x. Epub 2011 Sep 30.
8
Social support modifies the relationship between personality and depressive symptoms in older adults.社会支持可以调节老年人个性和抑郁症状之间的关系。
Am J Geriatr Psychiatry. 2011 Feb;19(2):123-31. doi: 10.1097/jgp.0b013e3181f7d89a.
9
Comparison of depressive symptom severity scores in low-income women.比较低收入女性的抑郁症状严重程度评分。
Nurs Res. 2010 Nov-Dec;59(6):380-8. doi: 10.1097/NNR.0b013e3181f84ee9.
10
Quetiapine augmentation of paroxetine CR for the treatment of refractory generalized anxiety disorder: preliminary findings.喹硫平增效缓释帕罗西汀治疗难治性广泛性焦虑障碍：初步研究结果。
Psychopharmacology (Berl). 2008 May;197(4):675-81. doi: 10.1007/s00213-008-1087-x. Epub 2008 Feb 2.